Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis
- PMID: 23626904
- PMCID: PMC3636503
Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis
Abstract
Pulmonary arterial hypertension (PAH) is a devastating disease with limited therapeutic options. Moreover, when PAH occurs in patients diagnosed with systemic sclerosis, worse outcomes are observed. The purpose of this review is to discuss the etiologies of PAH found in the systemic sclerosis patient, limitations of current medical therapies, and, finally, potential therapies for patients with this combination.
Keywords: connective tissue disease; pulmonary arterial hypertension; pulmonary hypertension; systemic sclerosis.
Similar articles
-
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.Integr Blood Press Control. 2020 Mar 23;13:15-29. doi: 10.2147/IBPC.S232038. eCollection 2020. Integr Blood Press Control. 2020. PMID: 32280271 Free PMC article. Review.
-
Connective tissue disease-associated pulmonary arterial hypertension.F1000Prime Rep. 2015 Jan 5;7:06. doi: 10.12703/P7-06. eCollection 2015. F1000Prime Rep. 2015. PMID: 25705389 Free PMC article. Review.
-
Pulmonary Hypertension in Systemic Sclerosis.Semin Respir Crit Care Med. 2024 Jun;45(3):411-418. doi: 10.1055/s-0044-1782607. Epub 2024 Mar 26. Semin Respir Crit Care Med. 2024. PMID: 38531379 Review.
-
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.Heart Fail Clin. 2023 Jan;19(1):45-54. doi: 10.1016/j.hfc.2022.08.016. Heart Fail Clin. 2023. PMID: 36435572 Review.
-
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.Rheumatology (Oxford). 2024 Apr 2;63(4):1139-1146. doi: 10.1093/rheumatology/kead360. Rheumatology (Oxford). 2024. PMID: 37462520 Free PMC article.
References
-
- Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010 Jun 15;69(10):1809–15. - PubMed
-
- Silman AJ. Scleroderma–demographics and survival. J Rheumatol Suppl. 1997 May;48:58–61. - PubMed
-
- Mayes MD, Lacey JV, Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003 Aug;48(8):2246–55. - PubMed
-
- McLaughlin V, Humbert M, Coghlan G, Nash P, Steen V. Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis. Rheumatology (Oxford) 2009 Jun;48(Suppl 3):iii25–31. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources